Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy

Ritter, V; Krautter, F; Klein, D; Jendrossek, V; Rudner, J

Rudner, J (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Cell Biol Canc Res, Essen, Germany.

CELL DEATH & DISEASE, 2021; 12 (7):